comscoreResearch News

Research News

Find out what the latest clinical trial results mean for you.
More from this topic
1365 Research news
 
 
Article
Risk of Early-Stage Breast Cancer Recurring 10 or More Years After Diagnosis Linked to Estrogen Receptor Status, Other Factors

The risk of early-stage breast cancer recurring 10 or more years after diagnosis is linked to the size of the cancer, the number of lymph nodes that contain cancer, and whether the cancer is estrogen receptor-positive.

Dec 1, 2021 | Diagnosis and Hormonal Therapy
 
Article
Some Breast Cancers May Switch HER2 Status if They Come Back

If breast cancer comes back — called recurrence by doctors — the HER2 status of the recurrent cancer may change from HER2-positive or HER2-negative to a new classification of HER2 status, called HER2-low.

May 18, 2021 | Diagnosis
 
Article
Even Small HER2-Positive Cancers Have Higher Recurrence Risk

Small (1 cm or smaller), early-stage, HER2-positive breast cancers are more likely to come back (recur) and spread to parts of the body away from the breast (metastasize) than small, early-stage HER2-negative breast cancers, which suggests that treating these cancers with Herceptin (chemical name: trastuzumab) may make sense.

Nov 4, 2009 | Diagnosis and Targeted Therapy
 
Article
Treating Early-Stage, HER2-Positive Disease With Herceptin and Chemo Combo With No Anthracycline Reduces Heart Risks

A study has found that Herceptin plus chemotherapy that didn't include an anthracycline after surgery was as effective as Herceptin plus chemotherapy that included an anthracycline for women diagnosed with HER2-positive, early-stage breast cancer.

 
Article
Vitamin D, Omega-3s, and Strength Exercises May Reduce Cancer Risk in Older People

Simple at-home strength exercises plus vitamin D and omega-3 supplements seemed to reduce cancer risk in healthy people age 70 and older.

May 12, 2022 | Risk Factors
 
Article
Vaccinated People Diagnosed With Cancer Have Higher Risk of Breakthrough COVID-19 Infection

People diagnosed with cancer who’ve received a COVID-19 vaccine have a higher risk of a breakthrough COVID infection than vaccinated people without cancer.

May 6, 2022
 
Article
Which Breast Cancer Surgery Offers Better Long-Term Quality of Life?

Women were satisfied with their breasts 10 years after either lumpectomy and radiation or mastectomy and reconstruction for early-stage breast cancer. Still, women who had lumpectomy and radiation had better psychosocial and sexual well-being.

May 6, 2022 | Surgery
 
Article
Low Vitamin D Levels Linked to Higher Breast Cancer Risk in Black and Hispanic Women

Black and Hispanic women who had low levels of vitamin D in their blood were more likely to develop breast cancer than women with sufficient levels.

May 4, 2022 | Ethnicity and Risk Factors
 
Article
Enhertu Dramatically More Effective Than Kadcyla as Second Treatment for Metastatic HER2-Positive Breast Cancer

Enhertu more than doubled the 12-month progression-free survival rate than Kadcyla in people diagnosed with metastatic HER2-positive breast cancer that had been previously treated.

Sep 22, 2021 | Diagnosis and Targeted Therapy
 
Article
Financial Problems Linked to Worse Cancer Survival

In the United States, people receiving breast cancer treatment had higher mortality risk when they had financial problems versus when they didn’t.

Apr 29, 2022 | Day-to-Day Matters
 
Article
Screening Mammography Rates Drop in Breast Cancer Survivors

Rates of screening mammograms among women who’ve received breast cancer treatment have declined since 2009, especially among women ages 40 to 49.

 
Article
Smoking Increases Breast Risk in Postmenopausal Women

Cigarette smoking (either past or present) and exposure to second-hand smoke increase breast cancer risk in postmenopausal women.

Mar 4, 2011 | Risk Factors
 
Article
Cold Therapy May Help Prevent Hair Loss, Skin, Nail Side Effects Caused by Taxane Chemotherapy

A meta-analysis suggests that cold therapy (including cold caps, frozen gloves, and frozen socks) can help prevent some of the hair loss, as well as skin and nail side effects, caused by taxane chemotherapy.

Nov 13, 2018 | Chemotherapy
 
Article
Multigene Testing of Everyone Diagnosed With Breast Cancer Deemed Cost-Effective, and Researchers Say Policies Should Change

A study found testing all people diagnosed with breast cancer for mutations in three genes linked to a high risk of the disease (BRCA1, BRCA2, and PALB2) would be "extremely cost-effective" compared to testing based on family history or clinical guidelines in the United States and the United Kingdom.

Oct 8, 2019 | Risk Factors
 
Article
Interval Breast Cancers Found Between Regular Screening Mammograms Seem More Aggressive

Breast cancers found in between regular screening mammograms (called interval cancers by doctors) were more likely to have aggressive characteristics, and women diagnosed with them were more likely to die from breast cancer compared to breast cancers found by routine screening.

Oct 27, 2020 | Screening and Testing
 
Article
Group Therapy Helps Ease Breast Cancer Stress

A breast cancer diagnosis can bring out so many difficult emotions(ear, anger, resentment, hopelessness, and more. It is a big challenge to learn how to cope with these feelings along with the stress ...

 
Article
Home-Based Weight Loss, Exercise Programs Don't Help Breast Cancer-Related Lymphedema

Neither weight loss nor at-home exercise programs (nor a combination of the two) improved lymphedema beyond the standard of care in overweight women who had been treated for breast cancer.

Aug 26, 2019 | Exercise and Side Effects
 
Article
Supervised Exercise Safe for People With Bone Metastases

People diagnosed with metastatic cancer that has spread to the bones can safely participate in supervised exercise programs, according to a review of 17 studies.

 
Article
Xgeva Better Than Zometa at Reducing Risk of Bone Problems in Women With Metastatic Disease

Research suggests that Xgeva is better than Zometa at reducing the risk of bone complication and improves quality of life more in women diagnosed with metastatic breast cancer that has spread to the bones.

 
Article
COVID-19 Outcomes Worse for Black Cancer Patients

Among Black people and white people diagnosed with cancer and COVID-19, Black people had worse COVID outcomes than white people.

Apr 1, 2022 | Ethnicity
 
Article
Light Therapy May Ease Fatigue and Improve Sleep for Breast Cancer Survivors

Wearing a light therapy visor cap at home improved sleep and eased fatigue in women who completed treatment for early-stage breast cancer.

Apr 1, 2022 | Diagnosis and Side Effects
 
Article
People Diagnosed With Cancer Benefit From Moderna COVID-19 Vaccine

People diagnosed with cancer developed COVID-19 antibodies after receiving the Moderna vaccine, but at lower levels than people who hadn’t been diagnosed with cancer.

Mar 29, 2022 | Diagnosis
 
Article
Sitting More, Inactivity Linked to Worse Outcomes for Cancer Survivors

Not exercising and lots of sitting can be harmful for cancer survivors.

Mar 25, 2022 | Exercise
 
Article
Molecular Differences in Breast Cells May Partially Explain Why Black Women Have Higher Breast Cancer Mortality

Breast cells in Black women express DNA repair genes differently from breast cells in white women and may be part of the reason why Black women are 41% more likely to die from breast cancer than white women.

Mar 9, 2022 | Ethnicity
Showing 24 of 1365